MicroRNA profiling in ocular adnexal lymphoma: A role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5169-5174

  Hother, Christoffer ^a   Rasmussen, Peter Kristian ^b   Joshi, Tejal ^c   Reker, Ditte ^a   Ralfkiær, Ulrik ^a   Workman, Christopher T ^c   Heegaard, Steffen ^b   Ralfkiær, Elisabeth ^a   Grønbæk, Kirsten ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

DLBCL; EZML; MicroRNA; Ocular adnexal lymphoma

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 101; MICRORNA 125B; MICRORNA 143; MICRORNA 145; MICRORNA 16; MICRORNA 221; MICRORNA 222; MICRORNA 24; MICRORNA 29; MYC PROTEIN; RITUXIMAB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; EYE CANCER; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MARGINAL ZONE LYMPHOMA; MICROARRAY ANALYSIS; OCULAR ADNEXAL LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DLBCL; EZML; MICRORNA; OCULAR ADNEXAL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; CONJUNCTIVAL NEOPLASMS; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACRIMAL APPARATUS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICRORNAS; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; ORBITAL NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 84881140521     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12272     Document Type: Article

References (32)

1. Woo JM, Tang CK, Rho MS, et al. The clinical characteristics and treatment results of ocular adnexal lymphoma. Korean J Ophthalmol. 2006;20:7-12.
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252-260.
3. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery lecture, part 1. Ophthalmology. 2004;111:997-1008.
4. Sjö LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol. 2009;87(Thesis 1):1-20.
5. Rosado MF, Byrne GE, Ding F, et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with chlamydia psittaci. Blood. 2006;107:467-472.
6. Cowland JB, Hother C, Grønbæk K. MicroRNAs and cancer. APMIS. 2007;115:1090-1106.
7. Esquela-Kerscher A, Slack FJ. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-269.
8. Saito Y, Liang G, Egger G, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 2006;9:435-443.
9. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11:726-734.
10. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: IARC Press; 2008.
11. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
12. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; ISBN 3-900051-07-0, 2008. Available at: http://www.R-project.org.
13. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, et al., eds. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York, NY: Springer; 2005:397-420.
14. Ritchie ME, Silver J, Oshlack A, et al. A comparison of background correction methods for two-colour microarrays. Bioinformatics. 2007;23:2700-2707.
15. Smyth GK, Speed T. Normalization of cDNA microarray data. Methods. 2003;31:265-273.
16. Dweep H, Sticht C, Pandey P, Gretz N. Mirwalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011;44:839-847.
17. Wang J, Lu M, Qiu C, Cui Q. Transmir: a transcription factormicroRNA regulation database. Nucleic Acids Res. 2009;38: D119-D122.
18. Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by MYC contributes to tumorigenesis. Nat Genet. 2008;40:43-50.
19. Mott JL, Kurita S, Cazanave SC, et al. Transcriptional suppression of miR-29b-1/miR-29a promoter by c-MYC, hedgehog, and NF-kB. J Cell Biochem. 2010;110:1155-1164.
20. Sander S, Bullinger L, Klapproth K, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008;112:4202-4212.
21. Chang TC, Zeitels LR, Hwang HW, et al. Lin-28b transactivation is necessary for MYC-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A. 2009;106:3384-3389.
22. Craig VJ, Cogliatti SB, Imig J, et al. MYC-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FOXP1. Blood. 2011;117:6227-6236.
23. Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010;362:1417-1429.
24. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kB, lin28, let-7 microRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139:693-706.
25. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007;26: 4148-4157.
26. Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE. A region of the human HOXD cluster that confers polycombgroup responsiveness. Cell. 2010;140:99-110.
27. Sakhinia E, Glennie C, Hoyland JA, et al. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood. 2007;109:3922-3928.
28. Wang H, Garzon R, Sun H, et al. NF-kB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell. 2008;14:369-381.
29. Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global dna hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3a and 3b and indirectly DNMT1. Blood. 2009;113:6411-6418.
30. Zhao JJ, Lin J, Lwin T, et al. MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010;115:2630-2639.
31. Martín-Subero JI, Kreuz M, Bibikova M, et al. New insights into the biology and origin of mature aggressive b-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood. 2009;113:2488-2497.
32. Quivoron C, Couronné L, Della Valle V, et al. Tet2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell. 2011;20:25-38.